Document is current
Any future updates will be listed below
-
Authors
Wang, JunShi
Kenny, Paul J. https://orcid.org/0000-0003-2426-3641
- License Information
-
More Information
Article History
First Online: 23 July 2025
Competing interests
: P.J.K. is a cofounder of Eolas Therapeutics, is a consultant for EpiVario and Exavir, and receives research funding from Eli Lilly. J.W. declares no competing interests.
